IPP Bureau
Briefs: Marksans Pharma and Alkem
By IPP Bureau - June 22, 2022
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
Agilent Laboratory achieves Green Lab certification
By IPP Bureau - June 22, 2022
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
By IPP Bureau - June 22, 2022
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics
By IPP Bureau - June 22, 2022
Bringing next-gen cannabinoid therapeutics to cancer patients
Atik Cameras launches ChemiMOS for long exposure imaging
By IPP Bureau - June 22, 2022
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
Sadhana Nitro Chem commences production of its 1st para aminophenol plant
By IPP Bureau - June 22, 2022
The company is now introducing the product into the India pharmaceutical market.
Iktos and Zealand Pharma to develop AI technology for peptide drug design
By IPP Bureau - June 22, 2022
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
By IPP Bureau - June 22, 2022
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
By IPP Bureau - June 21, 2022
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Indira IVF inaugurates new centre in Delhi Patel Nagar
By IPP Bureau - June 21, 2022
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Cadila Pharma launches formulation development lab
By IPP Bureau - June 21, 2022
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Medix Biochemica acquires Bioresource Technology
By IPP Bureau - June 21, 2022
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Parexel expands patient access to clinical trials through new community alliance network
By IPP Bureau - June 21, 2022
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
India welcomes TRIPS waiver deal at WTO
By IPP Bureau - June 21, 2022
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
Unilever, Genomatica form venture to develop palm oil based alternatives
By IPP Bureau - June 20, 2022
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
